Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biomarin Pharmaceutical (BMRN)
Technical Analysis Report for USA stock BMRN Biomarin Pharmaceutical. Dated: 08 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical then click here. or read Experts views on Biomarin Pharmaceutical or Forecast & share price targets of Biomarin Pharmaceutical
Biomarin Pharmaceutical Opened at 61.00 and Closed at: 60.35, which is -1.59% of previous session's close. It moved within a range of 59.80 and 61.28
The session was a Bearish session with an average volume of 2148100, which is -2.9% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Golden cross was found 1 days back on long term averages
Support for tomorrow is 59.34 and resistance for tomorrow is 60.82
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 59.67, 59 resistance for tomorrow's hourly charts is 61.15, 61.96
10 Day SMA for Biomarin Pharmaceutical (BMRN) is 59.86 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Biomarin Pharmaceutical (BMRN) is 57.39 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Biomarin Pharmaceutical (BMRN) is 55.24 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 55.22 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Biomarin Pharmaceutical is 57.19 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Biomarin Pharmaceutical is at 57.39 and 200 DMA is at 57.19, while 50 DMA and 100 DMA are at 55.24 and 55.22 respectively
Biomarin Pharmaceutical (BMRN) moving average of 20 SMA is at 57.39 and 20 EMA is at 58.16
| Date | Closing Price | 20 SMA | 20 EMA |
| 08 Thu Jan | 60.35 | 57.39 | 58.16 |
| 07 Wed Jan | 61.31 | 57.06 | 57.93 |
| 06 Tue Jan | 60.08 | 56.66 | 57.57 |
| 05 Mon Jan | 58.87 | 56.33 | 57.31 |
| 02 Fri Jan | 59.45 | 56.07 | 57.15 |
| 31 Wed Dec | 59.43 | 55.82 | 56.91 |
Biomarin Pharmaceutical (BMRN) moving average of 50 SMA is at 55.24 and 50 EMA is at 56.32
| Date | Closing Price | 50 SMA | 50 EMA |
| 08 Thu Jan | 60.35 | 55.24 | 56.32 |
| 07 Wed Jan | 61.31 | 55.08 | 56.16 |
| 06 Tue Jan | 60.08 | 54.95 | 55.95 |
| 05 Mon Jan | 58.87 | 54.84 | 55.78 |
| 02 Fri Jan | 59.45 | 54.73 | 55.65 |
| 31 Wed Dec | 59.43 | 54.61 | 55.49 |
Biomarin Pharmaceutical (BMRN) moving average of 100 SMA is at 55.22 and 100 EMA is at 56.18
| Date | Closing Price | 100 SMA | 100 EMA |
| 08 Thu Jan | 60.35 | 55.22 | 56.18 |
| 07 Wed Jan | 61.31 | 55.19 | 56.1 |
| 06 Tue Jan | 60.08 | 55.15 | 55.99 |
| 05 Mon Jan | 58.87 | 55.13 | 55.91 |
| 02 Fri Jan | 59.45 | 55.13 | 55.85 |
| 31 Wed Dec | 59.43 | 55.1 | 55.78 |
Biomarin Pharmaceutical (BMRN) moving average of 200 SMA is at 57.19 and 200 EMA is at 58.62
| Date | Closing Price | 200 SMA | 200 EMA |
| 08 Thu Jan | 60.35 | 57.19 | 58.62 |
| 07 Wed Jan | 61.31 | 57.25 | 58.6 |
| 06 Tue Jan | 60.08 | 57.3 | 58.57 |
| 05 Mon Jan | 58.87 | 57.35 | 58.55 |
| 02 Fri Jan | 59.45 | 57.42 | 58.55 |
| 31 Wed Dec | 59.43 | 57.47 | 58.54 |
Biomarin Pharmaceutical has performed better than Arcus Biosciences in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Haemonetics Corporation in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Xeris Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 4.62% more returns!
Sol Gel has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Sol Gel, about 19.25% more returns!
Regenxbio Inc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Regenxbio Inc, about 2.47% more returns!
Uniqure N has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Uniqure N, about 2.62% more returns!
Omeros Corporation has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Omeros Corporation, about 7.19% more returns!
National Research has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in National Research, about 2.74% more returns!
Biomarin Pharmaceutical has performed better than Nature S in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Mannkind Corporation in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Merit Medical in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Inovio Pharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Corvus Pharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Casi Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Casi Pharmaceuticals, about 15% more returns!
Biomarin Pharmaceutical has performed better than Biogen Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Avadel Pharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Array Biopharma in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Angiodynamics Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Agenus Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical Technical analysis of indicators
Price action analysis of Biomarin Pharmaceutical (BMRN) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biomarin Pharmaceutical in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 59.87 and Biomarin Pharmaceutical BMRN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical BMRN stock. Volume based technical analysis of Biomarin Pharmaceutical BMRN stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BMRN Experts View which covers a lot of information including buying and selling signals
BMRN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biomarin Pharmaceutical or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


